Harri J. Sihto
Helsinki, 00014, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 69 publications
Pan-cancer ex vivo target evaluation of phosphodiesterase 3 A (PDE3A).
Journal: Journal of molecular medicine (Berlin, Germany)
Published: December 04, 2025
Corrigendum to Mutant p53-associated myosin-X upregulation promotes breast cancer invasion and metastasis.
Journal: The Journal of clinical investigation
Published: December 01, 2025
High YEATS4 expression characterizes MDM2-amplified liposarcoma.
Journal: Cancer genetics
Published: July 03, 2025
Antiviral regulator TRIM25 as a prognostic marker of better survival in Merkel cell carcinoma: Association with MCPyV status.
Journal: International journal of cancer
Published: May 03, 2025
Phosphodiesterase 3 A expression in gastrointestinal stromal tumors.
Journal: Virchows Archiv : an international journal of pathology
Published: May 02, 2025
Kit-mediated autophagy suppression driven by a viral oncoprotein emerges as a crucial survival mechanism in Merkel cell carcinoma.
Journal: Autophagy
Published: March 20, 2025
RNA-Sequencing Reveals Two Subgroups of Eccrine Porocarcinomas and Poromas.
Journal: Journal of cellular and molecular medicine
Published: March 03, 2025
Fibroblast growth factor receptor expression in hemangioblastomas: A novel therapeutic target.
Journal: PloS one
Published: September 10, 2024
Whole-exome sequencing identifies distinct genomic aberrations in eccrine porocarcinomas and poromas.
Journal: Orphanet journal of rare diseases
Published: July 03, 2024
IGF2BP3 As a Prognostic Biomarker and Regulator of Metastasis in Merkel Cell Carcinoma.
Journal: JID innovations : skin science from molecules to population health
Published: May 30, 2024
Last Updated: 09/26/2026